Dementia
Cardiorespiratory fitness protects against dementia
Safety and effects of bosutinib in Lewy body dementia

Computational model of Alzheimer’s links symptoms, brain anatomy, mental processing
Biogen publishes Alzheimer’s drug data in lesser-known journal
Tau buildup in brain tied to psychosis, more rapid decline in Alzheimer’s disease
Alzheimer’s-like changes seen in COVID-19 patients’ brains
Reduced risk of Alzheimer’s disease in CHIP carriers
Post-traumatic amnesia, chronic vascular lesions risk factors for Alzheimer’s after TBI
Online self-test detects mild cognitive impairment shift to dementia sooner than MMSE
Researchers find ‘promising’ blood biomarkers for cognitive decline in dementia
MEF2 expression linked to cognitive resilience in Alzheimer’s disease
Tau replication in local brain regions, not spread between regions, drives Alzheimer’s pathology
Tau accumulation in brain likely best biomarker of short-term cognitive decline in Alzheimer’s
Study questions screening for subclinical thyroid dysfunction to prevent cognitive decline

Severe outcomes of COVID-19 in patients with dementia
Promising diagnostic accuracy of plasma GFAP
Sex modulates effect of cognitive reserve on subjective cognitive decline
Hypersensitivity to uncertainty in subjective cognitive decline
APOE-e4 allele tied to Alzheimer’s clinical and biomarker changes in Down syndrome
Calculator validated for home-based dementia risk screening
Statins not tied to incident dementia or cognitive decline in older adults
Motor change patterns may suggest preclinical Alzheimer’s disease
Obstructive sleep apnoea associated with lower cognition
NfL is a better marker for neurodegeneration than T-tau
Monoclonal antibody rapidly reduces brain amyloid
Pimavanserin does not worsen motor function in patients with neurodegenerative disease
Lipophilic statins may raise risk of conversion from MCI to dementia
Biological definition of Alzheimer’s disease not suitable for clinical diagnosis
Video exam may be effective alternative to in-person cognitive assessments
Dense-core amyloid plaques may be protective, not destructive, in Alzheimer’s disease
Whole-genome sequencing reveals rare variants tied to Alzheimer’s disease
More evidence that gum disease may play a role in Alzheimer’s disease
Retinal changes may signal pre-clinical Alzheimer’s disease neuropathology
Sargramostim shows promise in Alzheimer’s disease
Retinal damage may signal risk for stroke and dementia
Little consensus on referral to specialist palliative care for dementia patients
Link between cardiovascular-risk management and dementia protection remains elusive
Visual reads of PET scans can help predict near-term clinical progression of dementia
High risk of vascular dementia in patients with T2D
Study supports link between endosomal-traffic defect and Alzheimer’s
Neuroinflammation common in familial frontotemporal dementia
Predicting MCI and dementia by assessing worrying about memory
Genomics of vascular dementia and stroke
The PRISM project: focusing on biological parameters across neuropsychiatric disorders
![Table. ATN-profiles and corresponding biomarker categories [3].](https://dev.mc.sense-studios.com/wp-content/uploads/2020/09/Table.-ATN-profiles-and-corresponding.png)
Non-Alzheimer’s disease pathophysiology in the elderly
Novel genetic association with resistance to ERC tau deposition
Diastolic dysfunction novel risk factor for cognitive impairment
A necessary shift of focus to the earlier stages of Alzheimer’s
